| Up
2005P-0257:
Methylphenidate Hydrochloride Extended Release Tablets, 72 mg, is
Suitable for Submission as an ANDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 06/09/2005
|
| 06/22/2005
|
| Private Industry
|
| The Weinberg Group
Inc.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Nicholas M. Fleischer, R.Ph.,Ph.D.
|
|
|
|
|
| ACK1
|
| 06/22/2005
|
| 06/22/2005
|
| Federal Government
|
| HFA-305 to The Weinberg
Group Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
Top | Up
Page last updated
July 6, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
